ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early and in ...
Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of arthritis and psoriasis. Arthritis is a joint condition that causes pain and inflammation, and psoriasis is a ...
Obesity was linked to reduced long-term effectiveness of biologic therapy in patients with severe plaque psoriasis in a study, with dysregulated innate immune responses contributing to treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback